Bioequivalence Study for Fluticasone Propionate 500 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers
Clinical trial NCT06025214 · UNKNOWN
Trial details
- NCT number
- NCT06025214
- Sponsor
- Respirent Pharmaceuticals Co Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-22
- Primary completion
- 2023-09-22
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.